Mercer Global Advisors Inc Novartis Ag Transaction History

Mercer Global Advisors Inc

$35.2 Billion
Q1 2024

A detailed history of Mercer Global Advisors Inc transactions in Novartis Ag stock. As of the latest transaction made, Mercer Global Advisors Inc holds 147,770 shares of NVS stock, worth $15.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

147,770

Previous 111,066 33.05%

Holding current value

$15.7 Million

Previous $11.2 Million 27.47%

% of portfolio

0.04%

Previous 0.03%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$95.27 - $108.47 $3.5 Million - $3.98 Million	36,704 Added 33.05%	147,770 $14.3 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $263,061 - $289,490	2,851 Added 2.63%	111,066 $11.2 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $572,737 - $635,615	6,046 Added 5.92%	108,215 $11 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $939,170 - $1.06 Million	10,151 Added 11.03%	102,169 $10.3 Million
Q1 2023 May 15, 2023	SELL	$80.03 - $92.81 $340,767 - $395,184	-4,258 Reduced 4.42%	92,018 $8.47 Million

Q4 2022 Feb 08, 2023	SELL	$75.55 - $92.52 $39,814 - $48,758	-527 Reduced 0.54%	96,276 $8.73 Million
Q3 2022 Nov 15, 2022	BUY	$74.61 - $87.26 $167,051 - $195,375	2,239 Added 2.37%	96,803 $7.36 Million
Q2 2022 Aug 10, 2022	BUY	$80.52 - $93.75 $1.14 Million - $1.33 Million	14,190 Added 17.65%	94,564 $7.99 Million
Q1 2022 May 10, 2022	BUY	$80.11 - $90.62 $1.95 Million - $2.21 Million	24,334 Added 43.42%	80,374 $7.05 Million
Q4 2021 Feb 04, 2022	BUY	$79.7 - $88.13 $289,629 - $320,264	3,634 Added 6.93%	56,040 $4.9 Million
Q3 2021 Nov 10, 2021	BUY	$81.78 - $95.14 $914,545 - $1.06 Million	11,183 Added 27.13%	52,406 $4.29 Million
Q2 2021 Aug 10, 2021	SELL	$85.24 - $94.15 $372,498 - $411,435	-4,370 Reduced 9.58%	41,223 $3.76 Million
Q1 2021 Aug 10, 2021	BUY	$83.5 - $98.47 $60,537 - $71,390	725 Added 1.62%	45,593 $3.9 Million
Q1 2021 May 11, 2021	SELL	$83.5 - $98.47 $603,621 - $711,839	-7,229 Reduced 13.88%	44,868 $3.84 Million
Q4 2020 Feb 12, 2021	BUY	$78.07 - $94.43 $14,442 - $17,469	185 Added 0.36%	52,097 $4.92 Million
Q3 2020 Dec 10, 2020	SELL	$82.14 - $91.0 $2.61 Million - $2.89 Million	-31,722 Reduced 37.93%	51,912 $4.51 Million
Q2 2020 Aug 10, 2020	BUY	$80.93 - $91.1 $138,633 - $156,054	1,713 Added 2.09%	83,634 $7.31 Million
Q1 2020 May 18, 2020	BUY	$70.67 - $99.01 $1.05 Million - $1.48 Million	14,901 Added 22.23%	81,921 $6.75 Million
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $107,293 - $121,310	1,272 Added 1.93%	67,020 $6.35 Million
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $363,117 - $400,133	4,245 Added 6.9%	65,748 $5.71 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $909,776 - $1.12 Million	12,066 Added 24.41%	61,503 $5.62 Million
Q1 2019 Apr 23, 2019	BUY	$75.32 - $86.15 $465,778 - $532,751	6,184 Added 14.3%	49,437 $4.75 Million
Q1 2019 Apr 12, 2019	BUY	$75.32 - $86.15 $3.26 Million - $3.73 Million	43,253 New	43,253 $3.71 Million

Others Institutions Holding NVS

# of Institutions

1,343

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Novartis Ag Transaction History